» Articles » PMID: 8269947

Analysis of Two Mutated Vacuolar Proteins Reveals a Degradation Pathway in the Endoplasmic Reticulum or a Related Compartment of Yeast

Overview
Journal Eur J Biochem
Specialty Biochemistry
Date 1993 Dec 1
PMID 8269947
Citations 97
Authors
Affiliations
Soon will be listed here.
Abstract

The fate of a mutant form of each of the two yeast vacuolar enzymes proteinase yscA (PrA) and carboxypeptidase yscY (CPY) has been investigated. Both mutant proteins are rapidly degraded after entering the secretory pathway. Mutant PrA is deleted in 37 amino acids spanning the processing site region of the PrA pro-peptide. The mutant enzyme shows no activity towards maturation of itself or other vacuolar hydrolases, a function of wild-type PrA. Mutant CPY carries an Arg instead of a Gly residue in a highly conserved region, two positions distant from the active-site Ser. In contrast to wild-type CPY, the mutant form was quickly degraded by trypsin in vitro, indicating an altered structure. Using antisera specific for alpha-1-->6 and alpha-1-->3 outer-chain mannose linkages, no Golgi-specific carbohydrate modification could be detected on either mutant protein. Subcellular fractionation studies located both mutant enzymes in the endoplasmic reticulum. Degradation kinetics of both proteins show the same characteristics, indicating similar degradation pathways. The degradation process was shown to be independent of a functional sec18 gene product and takes place before Golgi-specific carbohydrate modifications occur. The proteasome, the major proteolytic activity of the cytoplasm, is not involved in this degradation event. All degradation characteristics of the two mutant proteins are consistent with a degradation process within the endoplasmic reticulum ('ER degradation').

Citing Articles

Initiation of ERAD by the bifunctional complex of Mnl1/Htm1 mannosidase and protein disulfide isomerase.

Zhao D, Wu X, Rapoport T Nat Struct Mol Biol. 2025; .

PMID: 39930008 DOI: 10.1038/s41594-025-01491-y.


TUDCA modulates drug bioavailability to regulate resistance to acute ER stress in .

Chadwick S, Stack-Couture S, Berg M, Di Gregorio S, Lung B, Genereaux J Mol Biol Cell. 2024; 36(2):ar13.

PMID: 39661468 PMC: 11809307. DOI: 10.1091/mbc.E24-04-0147.


Initiation of ERAD by the bifunctional complex of Mnl1 mannosidase and protein disulfide isomerase.

Zhao D, Wu X, Rapoport T bioRxiv. 2024; .

PMID: 39464000 PMC: 11507893. DOI: 10.1101/2024.10.17.618908.


Deep mutational scanning highlights a role for cytosolic regions in Hrd1 function.

Peterson B, Hwang J, Russ J, Schroeder J, Freddolino P, Baldridge R Cell Rep. 2023; 42(11):113451.

PMID: 37980570 PMC: 10751623. DOI: 10.1016/j.celrep.2023.113451.


The ERAD system is restricted by elevated ceramides.

Hwang J, Peterson B, Knupp J, Baldridge R Sci Adv. 2023; 9(2):eadd8579.

PMID: 36638172 PMC: 9839339. DOI: 10.1126/sciadv.add8579.